ReviewEndocrine, metabolic & immune disorders drug targets2026
Rebound Thymic Hyperplasia after Recovery from Ectopic Cushing Syndrome: A Case Report and Literature Review.
Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRebound thymic hyperplasia (RTH) is a rare benign condition resulting from compensatory proliferation of thymocytes after remission from stressful conditions, including hypercortisolism. Its appearance can sometimes be misleading, making differential diagnosis with thymic epithelial or neuroendocrine tumor challenging. CASE PRESENTATION: We describe the case of a 31-year-old patient who was referred to our outpatient clinic for worsening hirsutism, acne, and fatigue. Biochemical and dynamic tests showed an ACTH-dependent hypercortisolism of ectopic origin (Ectopic Cushing syndrome, ECS). An enhanced total body CT scan was performed to localize the tumor, revealing a 14 mm peribronchial nodule in the left upper lung that was surgically removed, leading to hypercortisolism resolution and hypoadrenalism. During a follow-up chest-abdomen CT scan, an anterior mediastinal enlargement was found. To better characterize the lesion, the patient underwent an enhanced MRI, which provided a conclusive diagnosis of RTH. This allowed the medical team to avoid unnecessary and invasive surgical thymectomy.
conclusionThe present case highlights the diagnostic importance of recognizing RTH as a benign mimic of thymic tumors in adults recovering from ectopic Cushing syndrome. Misinterpretation may lead to unnecessary surgical intervention. MRI may be useful to characterize RTH in a non-invasive way. Successful treatment requires collaboration among endocrinologists, surgeons, and radiologists.
Indexed as
Identifiers
42059219What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.